| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | Cambridge Nutritional Sciences Posts Pretax Loss In FY | 1 | RTTNews | ||
| CAMBRIDGE NUTRITIONAL SCIENCES Aktie jetzt für 0€ handeln | |||||
| 22.04. | Cambridge Nutritional Sciences flags lower revenue, small loss | 1 | Sharecast |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| VITRUVIA MEDICAL | 1,300 | 0,00 % | EQS-Adhoc: Vitruvia Medical AG: Halbjahresergebnis per 30.06.2026 | EQS-Ad-hoc: Vitruvia Medical AG / Schlagwort(e): Geschäftszahlen / Halbjahr/Prognose / Halbjahr
Vitruvia Medical AG: Halbjahresergebnis per 30.06.2026
12.08.2026 / 13:58 CET/CEST
Veröffentlichung... ► Artikel lesen | |
| PROGYNY | 27,150 | 0,00 % | Progyny auf Gesundheitskonferenz von Wells Fargo: Wachstumsperspektiven bleiben intakt | ||
| BRIGHTSPRING HEALTH SERVICES | 62,63 | 0,00 % | Can BTSG Outgrow the $20B Acute Infusion Market on Volume Growth? | ||
| HEARTFLOW | 47,730 | -0,04 % | Heartflow, Inc.: Late Breaking Data from Independent Government-Funded Trial at ESC Shows Heartflow FFRCT Analysis Reduces Unnecessary Invasive Heart Procedures by Nearly Half | FUSION trial presented at ESC and published in Journal of the American College of Cardiology demonstrates adding non-invasive lesion-specific physiology resolves critical diagnostic uncertainty, supporting... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 13,460 | 0,00 % | Kaplan Fox Encourages Investors of Alignment Healthcare, Inc. (NASDAQ: ALHC) to Contact the Firm Regarding Potential Securities Law Violations | ||
| ADAPTHEALTH | 6,190 | 0,00 % | AdaptHealth appoints Harriss Currie as CFO | ||
| AVEANNA HEALTHCARE | 13,650 | -0,07 % | Biotech Stocks At 52-Week Highs - Park Dental Partners +10%, Aveanna Healthcare +24%, Candel Therapeutics +10% on Q2 Reports, Labcorp Holdings, Hemab Therapeutics | LONDON (dpa-AFX) - The following biotech stocks reached 52-week highs on August 13, 2026, driven by key catalysts such as positive quarterly reports and the issuance of increased guidance figures.Park... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 12,795 | 0,00 % | LifeStance Health Group, Inc.: LifeStance Reports Strong Second Quarter 2026 Financial Results and Raises Full Year Outlook | SCOTTSDALE, Ariz., Aug. 06, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| BILLIONTOONE | 99,14 | +0,08 % | Canaccord initiates BillionToOne stock coverage with buy rating | ||
| PROCEPT BIOROBOTICS | 21,350 | 0,00 % | Kaplan Fox & Kilsheimer LLP Alerts PROCEPT BioRobotics Corporation (NASDAQ: PRCT) Investors to the Lead Plaintiff Deadline on September 22, 2026 | ||
| PRIVIA HEALTH GROUP | 20,800 | +0,10 % | Privia Health Group, Inc.: Privia Health Announces Appointment of Opella Ernest, M.D. to its Board of Directors | ARLINGTON, Va., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) announced the appointment of Opella Ernest, M.D. to its Board of Directors, effective September 1, 2026.... ► Artikel lesen | |
| BETA BIONICS | 19,340 | +0,05 % | Beta Bionics, Inc.: Beta Bionics Announces Second Quarter 2026 Financial Results and Updates Full Year 2026 Guidance | IRVINE, Calif., July 29, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| SANARA MEDTECH | 35,070 | +0,06 % | Sanara MedTech Inc. Reports Second Quarter 2026 Financial Results (Unaudited) | FORT WORTH, TX, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. ("Sanara," "Sanara MedTech," the "Company," "we," "our" or "us") (Nasdaq: SMTI), a medical technology company focused on developing... ► Artikel lesen | |
| GENEDX | 85,91 | +0,05 % | GeneDx: Starkes Wachstum trifft auf schwachen Forderungseinzug | ||
| FRESENIUS | 44,565 | -0,27 % | Fresenius schießt an die DAX-Spitze: Das steckt hinter dem Kurssprung | Die Fresenius-Aktie setzt sich am 8. September 2026 mit einem deutlichen Kurssprung an die Spitze des DAX. Das Papier gewinnt zeitweise rund 4,4 % und steigt auf etwa 45,20 Euro, während der deutsche... ► Artikel lesen |